BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Azadirachta indica {Neem} - Pseudomonas aeruginosa DHS01 |
👶
Microencapsulation of Azadirachta indica oil and Tinospora cordifolia extracts blend for single-use applications. Heliyon (Heliyon ) Vol: 10 Issue 20 Pages: e39163 Pub: 2024 Oct 30 Epub: 2024 Oct 9 Authors Khan O , Chandra Das S , Bedoura S , Html Article Publication |
| Azadirachta indica {Neem} - Pseudomonas aeruginosa DHS01 |
👶
To Evaluate and Compare the Antimicrobial Efficacy of Various Disinfecting Agents on K-file against Gram-positive and Gram-negative Bacteria of Endodontic Origin: An In Vitro Study. International journal of clinical pediatric dentistry (Int J Clin Pediatr Dent ) Vol: 16 Issue Suppl 2 Pages: 161-167 Pub: 2023 Sep Epub: Authors Opi K , Dhinsa K , Tripathi AM , Saha S , Html Article Publication |
| Azadirachta indica {Neem} - Pseudomonas aeruginosa DHS01 |
👶
Synergistic antimicrobial action of chitosan-neem extracts nanoformulation as a promising strategy for overcoming multi-drug resistant bacteria. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 272 Issue Pt 1 Pages: 132337 Pub: 2024 Jun Epub: 2024 May 24 Authors Almowallad SJ , Alqahtani LS , Publication |
| Azadirachta indica {Neem} - Pseudomonas aeruginosa DHS01 |
👶
Antimicrobial phytoconstituents from Azadirachta indica (neem) with potential inhibitor against FtsZ protein of Pseudomonas aeruginosa. Natural product research (Nat Prod Res ) Vol: Issue Pages: 1-6 Pub: 2024 Mar 22 Epub: 2024 Mar 22 Authors Orozco-Ugarriza ME , Arrieta Caldera NP , Olivo-Martínez Y , Publication |
| Azadirachta indica {Neem} - Pseudomonas aeruginosa DHS01 |
👶
Leaf extract of Azadirachta indica (neem): a potential antibiofilm agent for Pseudomonas aeruginosa. Pathogens and disease (Pathog Dis ) Vol: 69 Issue 1 Pages: 62-65 Pub: 2013 Oct Epub: 2013 Oct 1 Authors Harjai K , Bala A , Gupta RK , Sharma R , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
